1-4 of 4
Stephen Sze Yuen Lam
Close
Sort by
Journal Articles

Whole Exome Sequencing of FLT3-ITD Sorafenib-Resistant Acute Myeloid Leukaemia

Stephen Sze Yuen Lam, Chae Yin Cher, Nelson K. L. Ng, Cheuk Him Man, PhD, Anskar Y.H. Leung, MD
Journal: Blood
Blood (2015) 126 (23): 1400.
https://doi.org/10.1182/blood.V126.23.1400.1400
Published: 2015
Journal Articles

Development of a Clinically Relevant in Vitro Drug Screening Platform for Chemo-Refractory AML Patients

Stephen Sze Yuen Lam, Chae Yin Cher, Nelson Ka Lam Ng, Eric SK Ho, Cheuk Him Man, PhD, Howard CH Chow, Connie J Eaves, Alice MS Cheung, PhD, Anskar Y.H. Leung, MD
Journal: Blood
Blood (2014) 124 (21): 3624.
https://doi.org/10.1182/blood.V124.21.3624.3624
Published: 2014
Journal Articles

Bringing an Old Drug to a New Treatment Strategy in Treating FLT-ITD AML - Combination of Homoharringtonine and Sorafenib

Eric S.K. Ho, Stephen Sze Yuen Lam, Cheuk Him Man, PhD, Chae Yin Cher, Yok Lam Kwong, MD, Anskar Y.H. Leung, MD
Journal: Blood
Blood (2014) 124 (21): 3610.
https://doi.org/10.1182/blood.V124.21.3610.3610
Published: 2014
Journal Articles

A Novel Role Of Tescalcin-Sodium/Hydrogen Exchange Axis Underlying Sorafenib Resistance In FLT3-ITD + AML

Cheuk Him Man, Anskar Y.H. Leung, MD, Stephen Sze Yuen Lam, Murphy Ka Hei Sun, Howard Chun Hung Chow, Harinder Gill, MBBS, MRCP (UK), Yok Lam Kwong, MD
Journal: Blood
Blood (2013) 122 (21): 3848.
https://doi.org/10.1182/blood.V122.21.3848.3848
Published: 2013